Eosinophilic granulomatosis with polyangiitis after COVID-19: A case report.

Karampoor, Sajad; Afrashteh, Fatemeh; Rahmani, Shahrzad; Laali, Azadeh

Karampoor, Sajad; Afrashteh, Fatemeh; Rahmani, Shahrzad; Laali, Azadeh.

Karampoor S; Gastrointestinal and Liver Diseases Research Center, Iran University of Medical Sciences, Tehran, Iran.
Afrashteh F; Department of Virology, School of Medicine, Iran University of Medical Sciences, Tehran, Iran.
Rahmani S; Student Research Committee, School of Medicine, Iran University of Medical Sciences, Tehran, Iran.
Laali A; Department of Rheumatology, Firoozgar Clinical Research Development Center (FCRDC), Iran University of Medical Sciences, Tehran, Iran.

Respir Med Case Rep ; 38: 101702, 2022.

Article in English | MEDLINE | ID: covidwho-1926877

ABSTRACT

ABSTRACT

COVID-19 can damage the endothelial cells of every organ in the body and lead to vasculopathy and vasculitis. It has been shown that various types of vasculitis could be a new manifestation of COVID-19. Eosinophilic granulomatosis with polyangiitis (EGPA) is a rare systemic necrotizing vasculitis that affects small vessels. Here we report our experience with a 42-year-old man with a 3-weeks history of fever of unknown origin after two months from COVID-19 recovery presented with loss of appetite, loss of weight, and paresthesia in his lower extremities. After required evaluations including nerve biopsy, EGPA was diagnosed for him.

Keywords

COVID-19; Eosinophilic granulomatosis with polyangiitis; Fever of unknown origin; Leucocytoclastic vasculitis

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Type of study: Case report / Experimental Studies / Prognostic study Language: English Journal: Respir Med Case Rep Year: 2022 Document Type: Article Affiliation country: J.rmcr.2022.101702

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google